Although KRASG12V mutation and KRASG12V mutation with effector domain mutation46 were induced in CRC cell lines (such as Colo320 and Caco-2) containing wild-type KRAS and BRAF alleles, these mutations did not lead to decreased expression of RCAN2 (data not shown). This evidence concerns the gene KRAS and colorectal carcinoma.